Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

Clinical trial NCT02593123 · COMPLETED

Trial details

NCT number: NCT02593123
Sponsor: Virginia Commonwealth University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma Lymphoid Leukemia Lymphoma Leukemia Myeloma Acute Lymphocytic Leukemia Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma Chronic Myelogenous Leukemia Myelodysplastic Syndromes Recurrent Acute Myeloid Leukemia, Adult

Start date: 2015-11-04
Primary completion: 2022-03-18
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.